Cargando…

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands

Adoptive transfer of γδ T cells is a novel immunotherapeutic approach to glioblastoma. Few recent studies have shown the efficacy of γδ T cells against glioblastoma, but no previous studies have identified the ligand–receptor interactions between γδ T cells and glioblastoma cells. Here, we identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Haeyoun, Lee, Yunkyung, Park, Soon A, Lee, Ji Hyeon, Park, Junseong, Park, Jang Hyun, Lee, Heung Kyu, Kim, Tai-Gyu, Jeun, Sin-Soo, Ahn, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629076/ https://www.ncbi.nlm.nih.gov/pubmed/36338147 http://dx.doi.org/10.1080/2162402X.2022.2138152

Ejemplares similares

Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma
por: Choi, Haeyoun, et al.
Publicado: (2023)

HLA polymorphisms and risk of glioblastoma in Koreans
por: Choi, Sang-Soo, et al.
Publicado: (2021)

γδ T cells as a potential therapeutic agent for glioblastoma
por: Kang, In, et al.
Publicado: (2023)

Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ γδ T Cells in AML Patients
por: Jin, Zhenyi, et al.
Publicado: (2020)

γδ T Cells in Brain Homeostasis and Diseases
por: Park, Jang Hyun, et al.
Publicado: (2022)

Function of γδ T cells in tumor immunology and their application to cancer therapy
por: Park, Jang Hyun, et al.
Publicado: (2021)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy
por: Her, Jung Hyun, et al.
Publicado: (2022)

Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
por: Niu, Chao, et al.
Publicado: (2016)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8(+) T cells
por: Choi, Haeyoun, et al.
Publicado: (2023)

Double-edged sword: γδ T cells in mucosal homeostasis and disease
por: Kang, In, et al.
Publicado: (2023)

Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells
por: Yu, Hana, et al.
Publicado: (2012)

Protocol for analyzing γδ T cells from the vagina of diet-induced obese mice using single-cell RNA sequencing and flow cytometry
por: Kang, In, et al.
Publicado: (2023)

Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
por: Lamb, Lawrence S., et al.
Publicado: (2013)

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation
por: Kraus, Anna K., et al.
Publicado: (2016)

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
por: Veneziani, Irene, et al.
Publicado: (2019)

Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma
por: Lee, Changik, et al.
Publicado: (2020)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2(+) γδ T cell can be a promising complement
por: He, Wenjing, et al.
Publicado: (2022)

Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments
por: Ahn, Jaehyun, et al.
Publicado: (2022)

Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor
por: Juraske, Claudia, et al.
Publicado: (2018)

Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma
por: Wang, Yitian, et al.
Publicado: (2018)

γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis
por: Junqueira, Caroline, et al.
Publicado: (2021)

Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
por: Sandoz, Patrick A., et al.
Publicado: (2023)

BK Virus-Hemorrhagic Cystitis Following Allogeneic Stem Cell Transplantation: Clinical Characteristics and Utility of Leflunomide Treatment
por: Park, Young Hoon, et al.
Publicado: (2016)

Classification and function of γδT cells and its research progress in anti-glioblastoma
por: Zhao, Yujuan, et al.
Publicado: (2023)

DNAM-1: would the real natural killer cell please stand up!
por: Huntington, Nicholas D., et al.
Publicado: (2015)

DNAM-1 controls NK cell activation via an ITT-like motif
por: Zhang, Zhanguang, et al.
Publicado: (2015)

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
por: Mantovani, Stefania, et al.
Publicado: (2022)

The effect of activated Mϕ1 on γδT cell-mediated killing of gastric cancer cells in vitro
por: Xia, Wu, et al.
Publicado: (2016)

Study on the Killing Effect of γδT Cells Activated by Rukangyin on Breast Cancer MDA-MB-231 Cells
por: Chen, Zaiwang, et al.
Publicado: (2021)

Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model
por: Kim, Geun Soo, et al.
Publicado: (2020)

Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
por: Li, Qing, et al.
Publicado: (2022)

Coreceptors and Their Ligands in Epithelial γδ T Cell Biology
por: Witherden, Deborah A., et al.
Publicado: (2018)

γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022)

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
por: Fionda, Cinzia, et al.
Publicado: (2015)

Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
por: Fleischer, Lauren C., et al.
Publicado: (2020)

Retracted: Study on the Killing Effect of γδT Cells Activated by Rukangyin on Breast Cancer MDA-MB-231 Cells
por: Markers, Disease
Publicado: (2023)

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
por: Park, Jang Hyun, et al.
Publicado: (2022)

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
por: Gilfillan, Susan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_eej1b7o6gjrriuk5nrqedpojj9